CRL NYSE
Charles River Laboratories International, Inc.
1W: -0.9%
1M: -0.6%
3M: +25.4%
YTD: +43.3%
1Y: +70.2%
3Y: +48.8%
5Y: -36.7%
$290.19
+3.36 (+1.17%)
Weekly Expected Move ±4.9%
$261
$276
$290
$304
$319
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (100)
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Has Consensus Price Target of $290.00 According to Analysts
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
Charles River rises on Investor Day on promising 2026 outlook
Corient Private Wealth LP Reduces Holdings in Charles River Laboratories International, Inc. $CRL
PGNY vs. CRL: Which Stock Is the Better Value Option?
10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades
The Broyhill adds FCNCA; exits CRL, ACN, INTU, and HUBS
Beat the Market the Zacks Way: FIGS, Microsoft, Amphenol in Focus
Are Medical Stocks Lagging Amgen (AMGN) This Year?
Amundi Sells 360,913 Shares of Charles River Laboratories International, Inc. $CRL
Hsbc Holdings PLC Reduces Holdings in Charles River Laboratories International, Inc. $CRL
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?
Is This the Right Time to Add CRL Stock to Your Portfolio?
Wall Street Is Now Backing the Clarity Act. Here's the Most Likely Scenario for What Happens Next With Crypto.
Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?
Great Lakes Advisors LLC Makes New $459,000 Investment in Charles River Laboratories International, Inc. $CRL
CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?
Are Options Traders Betting on a Big Move in Charles River Stock?
Charles River Gains 88.6% in a Year: What's Driving the Rally?
Empowered Funds LLC Sells 2,156 Shares of Charles River Laboratories International, Inc. $CRL
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript
Charles River Laboratories International (NYSE:CRL) CAO Michael Gunnar Knell Sells 6,645 Shares
Charles River Laboratories International (NYSE:CRL) Sets New 52-Week High – Still a Buy?
International Markets and Charles River (CRL): A Deep Dive for Investors
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus
Charles River Laboratories International, Inc. Q2 2026 Earnings Call Summary
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-Market
Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?
Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Can These 3 MedTech Stocks Hit Targets This Earnings Season?
California State Teachers Retirement System Boosts Holdings in Charles River Laboratories International, Inc. $CRL
Avidity Partners Management LP Buys New Shares in Charles River Laboratories International, Inc. $CRL
Charles River Prepares to Report Q2 Earnings: What's in Store?
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Epoch Investment Partners Inc. Sells 21,131 Shares of Charles River Laboratories International, Inc. $CRL
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
Medpace leads a rally in CRO space after Q2 beat
Fifth Third Bancorp Buys 6,002 Shares of Charles River Laboratories International, Inc. $CRL
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
Medpace Growth Trends Show How CRO Demand Is Shifting in 2026
Medpace Stock Outlook Turns on Backlog Quality and Cancellations
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
Why is Morgan Stanley Bullish on Charles River Laboratories International, Inc. (CRL) as a Top Stock to Buy According to Ariel Investment?
LH or CRL: Which Is the Better Value Stock Right Now?
Is This the Right Time to Hold CRL Stock in Your Portfolio?
Is Charles River Laboratories International, Inc. (CRL) A Good Stock To Buy Now?
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
LH vs. CRL: Which Stock Is the Better Value Option?
Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus
Notable healthcare headlines for the week: UnitedHealthcare, Pfizer, Eli Lilly in focus
Notable healthcare headlines for the week: UnitedHealth, Boston Scientific, and Eli Lilly in focus
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
Most healthcare companies report higher Y/Y EPS in strong earnings week
LH vs. CRL: Which Stock Is the Better Value Option?
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
Charles River (CRL) Q1 2026 Earnings Transcript
Charles River reaffirms 2026 EPS $10.80-$11.30, targets ~120-150 bps margin expansion as divestitures close
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
Charles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates
Charles River Gears Up for Q1 Earnings: What's in the Cards?
William Blair updates conviction stock list
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock
What is Zacks Research’s Forecast for CRL Q3 Earnings?
Charles River Laboratories International, Inc. $CRL Shares Purchased by Assetmark Inc.
OpenAI launches GPT-Rosalind, an AI model for life sciences research
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Massachusetts Financial Services Co. MA Takes Position in Charles River Laboratories International, Inc. $CRL
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of “Moderate Buy” from Brokerages
Aberdeen Group plc Purchases 88,853 Shares of Charles River Laboratories International, Inc. $CRL
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
Assenagon Asset Management S.A. Increases Stake in Charles River Laboratories International, Inc. $CRL
Contravisory Investment Management Inc. Takes $1.22 Million Position in Charles River Laboratories International, Inc. $CRL
CIBC Private Wealth Group LLC Sells 5,141 Shares of Charles River Laboratories International, Inc. $CRL
Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report?
FDA issues guidance on alternatives to animal testing
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus
Algert Global LLC Buys 39,586 Shares of Charles River Laboratories International, Inc. $CRL
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of “Moderate Buy” by Brokerages
Research Analysts Offer Predictions for CRL Q1 Earnings